High SGK1 levels were found in the brains of suicide victims and in people with genetic variants linked to early adversity. Drugs that block SGK1 could offer a new kind of antidepressant, especially for patients resistant to SSRIs.
Related Posts
Blocking a single protein forces cancer cells to self-destruct: Study
Post Views: 7 When this protein, FSP1, was blocked, lung…
Hospital-insurer conflict: Will latest circular by NMC help in reducing the pain of health insurance policyholders?
Post Views: 28 The rational use of medicines and diagnostics…
On-ground barriers stalling private adoption of ABDM : Experts
Post Views: 26 At the 5th edition of the Healthcare…